PositoAI/ JP/ J-Pharma Co., Ltd.

J-Pharma Co., Ltd.

Tokyo: 520A · Healthcare

Positivity Index

#8,483 / 10,750

Global

#3,430 / 3,683

Japan

Positivity Score

18,924

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: not checked yet

J-Pharma Co., Ltd. — Overview & Financial Snapshot

J-Pharma Co., Ltd. (Tokyo: 520A) is a Healthcare company, ranked #8,483 of 10,750 companies globally and #3,430 of 3,683 in Japan on PositoAI, with a Positivity Score of 18,924. Its market capitalisation is ₹515.07 Cr (¥8.52B), P/E ratio is -5.0 and P/B ratio is 3.64. Red flags (PosiRed) are not checked yet for companies in this market.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Wel-Dish.Incorporated 27,767 #16 Kohjin Bio Co., Ltd. 25,987 #40 MTI Ltd. 25,486 #50 GIMIC Co., Ltd. 25,357 #53 PhoenixBio Co., Ltd. 25,318

— Nothing to show —

OpenAI is reading recent news...

J-Pharma Co., Ltd. is engaged in the research and development of pharmaceutical drugs in Japan. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including nanvuranlat (JPH203), a novel small-molecule compound identified as a selective inhibitor of LAT1 and provide treatment for biliary tract cancer, as well as for colorectal cancer; JPH034 is characterized as high brain penetrance and development for disorders of the central nervous system, including non-relapsing secondary progressive multiple sclerosis and glioma; and JPT-0008 for solid tumor, autoimmune diseases, and rare diseases. It also conducting clinical trail for biliary tract cancer and JPH034. The company was founded in 2005 and is based in Minato, Japan.

P/B Ratio 3.64

P/E Ratio -5.0

D/E Ratio 0.00

ROE -73.01%

Owes vs Owns ? 0.21× Low ¥0.21 owed for every ¥1 it owns · balance sheet Dec 2025

Dividend Yield 0.00%

Trailing EPS ₹-56.73¥-93.90

Forward EPS —

Beta —

Market Cap ₹515.07 Cr¥8.52B

What these numbers mean →

What does J-Pharma Co., Ltd. do?

What is J-Pharma Co., Ltd.'s P/E and P/B ratio?

J-Pharma Co., Ltd. has a P/E ratio of -5.0 and a P/B ratio of 3.64.

What is J-Pharma Co., Ltd.'s debt-to-equity ratio?

J-Pharma Co., Ltd. has a debt-to-equity ratio of 0.00.

How much does J-Pharma Co., Ltd. owe compared with what it owns?

J-Pharma Co., Ltd. owes ¥0.21 for every ¥1 it owns (balance sheet Dec 2025), which is low.

What is J-Pharma Co., Ltd.'s Positivity rank?

J-Pharma Co., Ltd. is ranked #8,483 of 10,750 companies globally and #3,430 of 3,683 in Japan on PositoAI, with a Positivity Score of 18,924.

Does J-Pharma Co., Ltd. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for J-Pharma Co., Ltd..

Where can I read the latest news about J-Pharma Co., Ltd.?

Recent headlines about J-Pharma Co., Ltd. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does J-Pharma Co., Ltd. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of J-Pharma Co., Ltd.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.